Australia and New Zealand Prothrombin Complex Concentrate Market Size, Share & Covid-19 Impact Analysis, By Product (4-factor PCC and 3-factor PCC), By Application (Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency and By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, and Others), 2020-2027

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI104761

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

1.Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Epidemiology of Coagulation Factor Deficiency in Australia and New Zealand
2. Recent Industry Developments – Partnerships, Mergers & Acquisitions
3. Regulatory Scenario – For Key Countries
4. Analysis in Relation to Alternatives to PCC
5. PCC Market: Reimbursement Scenario & Key Industry Trends
6. Impact of COVID-19 on PCC Market
Australia & New Zealand Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
  1. 3-factor PCC
  2. 4-factor PCC
3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
  1. Acquired Coagulation Factor Deficiency
  2. Congenital Coagulation Factor Deficiency
4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Others
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2019)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
  1. CSL Limited
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Grifols SA
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Octapharma AG
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. Sanquin
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Kedrion S.p.A
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. Shire (Takeda Pharmaceutical Company Limited)
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Other Players
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations

1.Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Epidemiology of Coagulation Factor Deficiency in Australia and New Zealand
2. Recent Industry Developments – Partnerships, Mergers & Acquisitions
3. Regulatory Scenario – For Key Countries
4. Analysis in Relation to Alternatives to PCC
5. PCC Market: Reimbursement Scenario & Key Industry Trends
6. Impact of COVID-19 on PCC Market
Australia & New Zealand Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
  1. 3-factor PCC
  2. 4-factor PCC
3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
  1. Acquired Coagulation Factor Deficiency
  2. Congenital Coagulation Factor Deficiency
4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Others
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2019)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
  1. CSL Limited
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Grifols SA
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Octapharma AG
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. Sanquin
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Kedrion S.p.A
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. Shire (Takeda Pharmaceutical Company Limited)
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Other Players
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Product, 2019 & 2027

Figure 2: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 3: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Application, 2019 & 2027

Figure 4: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 5: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (US$ Mn), by End User, 2019 & 2027

Figure 6: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 7: Global PCC Market Share Analysis (%), By Company, 2019

List of Tables

Table 1: Australia & New Zealand Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2016–2027

Table 2: Australia & New Zealand Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2016–2027

Table 3: Australia & New Zealand Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2016–2027

Australia and New Zealand Prothrombin Complex Concentrate Market

REPORT UPDATE
IN PROCESS
STUDY PERIOD: 2019-2032
(IN PROCESS)
BASE YEAR: 2024
(IN PROCESS)

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com